Skip to main content
    W

    Warby Parker Inc (WRBY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $25.48
    -0.61 (-2.32%)

    Market Cap: $2.63B

    Last updated: Nov 06, 2026 at 4:37 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    77%(17/22)
    Avg Surprise
    -2008.43%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.10
    Range$-0.03 - $0.18
    9 analysts
    Revenue Consensus
    $247M
    Range$242M - $262M
    13 analysts
    Last 12 of 26 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.10$-0.03 - $0.18--9--
    Sep 26
    Reported Nov 5
    		$0.05$0.03$0.02 - $0.06+66.67%Beat9
    No revisions (30d)
    		-58.3%
    Jun 26
    Reported Aug 6
    		$0.05$0.05-+0.00%Beat10
    2
    8
    30d
    		+150.0%
    Mar 26
    Reported May 7
    		$0.11$0.11$0.09 - $0.13+0.00%Beat10
    1
    0
    30d
    		-21.4%
    Dec 25
    Reported Feb 26
    		$-0.04$0.01$-0.02 - $0.04-500.00%Miss9
    1
    0
    30d
    		+33.3%
    Sep 25
    Reported Nov 6
    		$0.12$0.09$0.07 - $0.12+33.33%Beat10
    9
    1
    30d
    		+100.0%
    Jun 25
    Reported Aug 7
    		$0.02$0.02-+0.00%Beat10
    1
    0
    30d
    		-75.0%
    Mar 25
    Reported May 8
    		$0.14$0.11$0.10 - $0.14+27.27%Beat8
    2
    3
    30d
    		+27.3%
    Dec 24
    Reported Feb 27
    		$-0.06$0.03$0.01 - $0.06-300.00%Miss9
    4
    2
    30d
    		-500.0%
    Sep 24
    Reported Nov 7
    		$0.06$0.05$0.03 - $0.07+20.00%Beat7
    1
    0
    30d
    		+500.0%
    Jun 24
    Reported Aug 8
    		$0.08$0.05$0.04 - $0.06+60.00%Beat7
    No revisions (30d)
    		+100.0%
    Mar 24
    Reported May 9
    		$0.11$0.07$0.06 - $0.08+57.14%Beat7
    0
    1
    30d
    		+83.3%
    Dec 23
    Reported Feb 28
    		$-0.01$0.01$0.00 - $0.02-200.00%Miss7
    No revisions (30d)
    		+94.3%

    Key Metrics

    Valuation
    P/E Ratio149.85EV/EBITDA49.66x
    Price/FCF149.24xFCF Yield0.67%
    Profitability
    Profit Margin0.85%Operating Margin-3.60%
    ROE2.06%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.26xQuick Ratio1.97x
    Trading Statistics
    Beta1.95Avg Volume3.53M
    52-Week High$31.0052-Week Low$16.26

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$24.26
    SMA 20$24.79
    SMA 50$24.90
    SMA 200$25.07
    EMA 10$24.40
    EMA 20$24.66
    EMA 50$25.08
    EMA 200$24.88

    MACD

    Line: -0.33Signal: -0.32Hist: -0.01

    ADX

    ADX: 12.3+DI: 22.4-DI: 18.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down92.0
    PSAR$21.32

    Bollinger Bands

    Upper Band$27.46
    Lower Band$22.12
    %B Position2157%(Upper)
    Band Width0.63

    RSI (14-Day)

    Neutral
    52.7

    Momentum Oscillators

    Stoch %K49.5
    Stoch %D29.0
    Williams %R-31.4
    ROC (10d)-1.7%
    Momentum-0.43
    CCI (20d)93.6
    MFI (14d)44.2

    Volatility Measures

    ATR (14d)$1.90(7.5%)
    StdDev (20d)1.34
    Hist Vol99.1%(High)

    Volume Flow

    VWAP$26.11
    OBV37.7M
    AD Line14.6M
    CMF (20d)-0.309

    Volume Metrics

    Avg Vol (20d)3.7M
    Vol Ratio1.4x
    VWMA (20d)$24.57

    Pivot Points

    R3$29.99
    R2$28.71
    R1$27.40
    Pivot Point$26.12
    S1$24.81
    S2$23.53
    S3$22.22

    Advanced Oscillators

    TSI-6.19
    Ultimate Osc38.3
    KST-29.41

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$244.74M$235.51M$242.45M$211.97M$221.68M$214.47M$223.78M$190.64M$192.45M$188.22M$200.00M$161.85M
    Cost of Revenue$111.56M$99.05M$111.41M$100.92M$101.73M$100.87M$97.80M$87.52M$87.58M$82.84M$86.54M$74.79M
    Gross Profit$133.17M$136.46M$131.04M$111.05M$119.94M$113.61M$125.98M$103.13M$104.87M$105.38M$113.46M$87.07M
    Operating Expenses$129.61M$133.29M$129.37M$117.90M$116.38M$118.13M$123.51M$112.54M$111.48M$114.34M$118.59M$108.64M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$129.61M$133.29M$129.37M$117.90M$116.38M$118.13M$123.51M$112.54M$111.48M$114.34M$118.59M$108.64M
    Operating Income$3.56M$3.17M$1.67M$-6,852,000$3.57M$-4,525,000$2.47M$-9,416,000$-6,613,000$-8,956,000$-5,127,000$-21,569,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$6.17M$5.25M$4.00M$-5,091,000$5.75M$-2,541,000$4.93M$-6,784,000$-3,771,000$-6,389,000$-2,571,000$-19,152,000
    Income Tax Expense$563,000$607,000$821,000$862,000$-125,000$-789,000$1.45M$93,000$301,000$373,000$108,000$-105,000
    Net Income$5.60M$4.64M$3.18M$-5,953,000$5.87M$-1,752,000$3.47M$-6,877,000$-4,072,000$-6,762,000$-2,679,000$-19,047,000
    EBITDA$17.75M$16.52M$14.88M$9.02M$15.70M$6.93M$14.36M$6.39M$8.91M$5.67M$9.09M$-7,566,000
    EBIT$6.17M$5.25M$4.00M$-5,091,000$5.75M$-2,541,000$4.93M$-6,784,000$-3,771,000$-6,389,000$-2,571,000$-19,152,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about WRBY

    News

    Precision Trading with Warby Parker Inc. Class A (WRBY) Risk Zones

    This article provides a detailed analysis of Warby Parker Inc. Class A (WRBY) stock, highlighting proprietary signals, sentiment, and risk zones. It outlines three institutional trading strategies (Position...

    Stock Traders Daily•10/25/26•Somewhat-Bearish

    Warby Parker - Class A Share News - Latest Updates, Live News & More

    This article provides the latest news and performance data for Warby Parker (WRBY) Class A shares. It highlights the company's upcoming Q3FY26 earnings release on November 5, 2026...

    scanx.trade•10/24/26•Somewhat-Bullish

    Form 4 Warby Parker Inc: Neil Harris Blumenthal (Director, Co-Chief Executive Officer) For: 1 October

    This article reports on a Form 4 filing for Warby Parker Inc., indicating transactions by Neil Harris Blumenthal, a Director and Co-Chief Executive Officer...

    Investing.com Nigeria•10/13/26•Neutral

    Warby Parker co-CEO Neil Blumenthal sells $2.77m in stock

    Warby Parker co-CEO Neil Blumenthal sold 100,000 shares of the company's Class A Common Stock for $2.77 million on October 1, 2026, pursuant to a pre-arranged trading plan. Despite the stock's 22% gain over six months...

    Investing.com Nigeria•10/13/26•Somewhat-Bearish

    Warby Parker director Jeffrey Raider sells $415,500 in shares

    Warby Parker director and 10% owner Jeffrey Raider sold 15,000 shares of Class A Common Stock for $415,500 on October 1, 2026...

    Investing.com•10/13/26•Bearish

    WRBY Valuation and Fair Value

    P/E
    149.9x
    Forward P/E
    37.9x
    EV/EBITDA
    49.7x
    P/FCF
    149.2x
    P/B
    7.9x
    See GNG's fair value

    WRBY Profitability: Margins, ROIC and FCF

    Gross margin
    54.7%
    Operating margin
    -3.6%
    Net margin
    0.9%
    ROE
    2.1%
    FCF margin
    2.3%
    FCF yield
    0.7%

    WRBY Competitors

    CompanyTicker
    Progyny IncPGNY
    Maravai Lifesciences Holdings IncMRVI
    Regencell Bioscience Holdings LtdRGC
    Neogen CorporationNEOG
    Soleno Therapeutics IncSLNO
    Xencor IncXNCR
    Zai Lab LtdZLAB
    Guardian Pharmacy Services, Inc.GRDN

    Sector: Healthcare

    WRBY Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    2
    Buy
    8
    Hold
    3
    Sell
    0
    Strong Sell
    0

    WRBY Bull Case vs Bear Case

    Bull case

    • 76.9% of WRBY's analyst ratings are Buy or Strong Buy.

    Bear case

    • WRBY trades at 149.9x trailing earnings.
    • WRBY beat EPS estimates in 37.5% of its last 8 reported quarters.

    WRBY Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -84.1%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.10

    WRBY Earnings Date

    WRBY reports Feb 24, 2027, after the close. The date is estimated.

    WRBY Earnings Call

    The latest WRBY earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    WRBY ETF Holders

    GNG tracks 13 ETFs that hold WRBY. The largest weights:

    1. State Street SPDR S&P Retail ETF (XRT), 1.36% of the fund
    2. First Trust Small Cap Growth AlphaDEX Fund (FYC), 0.35% of the fund
    3. iShares Core S&P Small-Cap ETF (IJR), 0.15% of the fund
    4. Fidelity Blue Chip Growth K6 Fund (FBCGX), 0.14% of the fund
    5. Fidelity MSCI Consumer Discretionary Index ETF (FDIS), 0.11% of the fund
    Open the ETF Stock Exposure tool for WRBY

    See insider activity

    Frequently Asked Questions About WRBY

    When does WRBY report earnings?

    Warby Parker Inc (WRBY) is expected to report earnings on Feb 24, 2027.

    Does WRBY pay dividends?

    Warby Parker Inc (WRBY) does not currently pay a regular dividend.

    What is WRBY's P/E ratio?

    Warby Parker Inc has a price-to-earnings (P/E) ratio of 149.85.

    What is WRBY's market cap?

    Warby Parker Inc (WRBY) has a market capitalization of $2.63B with a current stock price of $25.48.

    Related stocks

    Sector: Healthcare

    All stocks starting with W

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In